Member Info for jackie1

Key highlights

· Lupuzor™ PK study on track to deliver results in Q1 2022 and to move into Phase 3 thereafter
· P140/Lupuzor™: new proprietary synthesis of P140 giving greater IP protection and cost efficiencies
· P140-CIDP moving into a Phase 2/3 adaptive registration clinical trial in 2022 with anticipated 'orphan drug' designation. Commercial partnering discussions ongoing
· Professor Sylviane Muller & CNRS relationship strengthened to exploit P140 opportunities
· BioAMB: Excellent results from pre-clinical study, with further significant updates anticipated in H1 2022. Commercial partnering discussions ongoing

Aminex is pleased to announce that it has received full payment from the Tanzania Petroleum Development Corporation ("TPDC") pursuant to the agreement with the TPDC. As previously announced, after distribution of JV partner shares of the gas sales and remittance of indirect taxes and export duties the Company will retain approximately US$1.85 million.

Innovative U.S. Distributor Fully Integrates Retail Presence of Chill Brands' CBD Products

"Europa Metals is taking a series of steps to ensure the allocation of funds for maximum effect at its Toral Project whilst simultaneously pursuing the potential acquisition of new, value accretive projects for the Company. We are also undertaking a full review of the Group's cost base, including board level remuneration packages, and establishing a clear strategic pathway through the remainder of 2021/2022 to refocus our efforts on delivering value for shareholders

"The first nine months of 2021 delivered strong growth in revenue, Netback and EBITDAX and resulted in a 50% increase in operating cash flows versus the same period in 2020, predominantly due to increased gas demand in Morocco and improved commodity pricing. The Company ended the period with a strong liquidity position and a significant net cash position of just under $10 million, which fully funds our work programmes for 2021 and 2022. Our producing assets in Egypt and Morocco continued to perform well in the period meaning that we remain above our mid-point guidance for the year with significant development opportunities in the next eighteen months to increase production further. We look forward to the imminent start of our second drilling campaign of the year in Morocco, drilling two wells before the year-end and obtaining the results of the first development well in a 13-well campaign at West Gharib in Egypt, which will give the Group the opportunity to instantly increase its exposure to the current high oil prices."

Strong Nickel, Copper and PGE anomalies defined in initial trenching and rock chip sampling programme at Elizabeth Hill

"I am delighted to announce that the first phase of the infill development drilling programme in TGT has finished, with all four wells testing at rates in line with or ahead of pre-drill expectations. The campaign was completed ahead of schedule and under budget. The well intervention programme conducted earlier in the year also delivered rates above expectations. Together, these two operational campaigns have increased production capacity and will ultimately improve recovery from the field. They also support the further activity set out in the Full Field Development Plan designed to optimise field oil & gas recovery and a submission request for a five-year contract term extension.

Hyve Group plc ("Hyve" or the "Company"), the next-generation global events business, announces that it has placed 13,818,698 new ordinary shares in the Company (the "Placing Shares") to raise gross proceeds of approximately £14.79m, representing approximately 5.21% of the Company's existing issued share capital, with institutional investors (the "Placing"). The Placing Shares have been placed at a price of 107 pence (the "Placing Price"), representing a discount of 0.7% to the closing market price on 17 November 2021.

Placing to raise £25 million and Open Offer to raise up to approximately £4.0 million

Payment of Kiliwani North Gas Receivables Further Update

Acquisition of 121 Group and Agreement with Lenders

So Monecor could be here to stay for a ride to 1p first ?

Note ; 900m volume

Easily can be sold and buy back 100m shares

Many large trades not included in the 900m volume

So from 22nd Sep to 17th Nov it is impossible for Monecor to sell just 5m shares lol

Note: in them 2 months the volume has been 800-900m

Something tells me Monecor sold out and rebought back for the clients

They wouldn’t want to miss out now

I don’t agree with that

Peter was selling holding well before Oct and the trades were all large ones seen in Sep

Imperial brand TR1 wasn’t till Oct so i would say it was taken in the open market new shares

The positive drill results have led to an extension of the drilling programme as follows:

- A step out hole will commence immediately on Untested Anomaly A

- Plans are being made to drill two further step out holes to the east of Hole 7 where the high grades have been discovered

- It has been decided to trench two further new anomalies to the south of Tombreen West

Nightmare

My worse performing stock, luckily its very small

Ongoing discussions with several potential litigation funders to support a potential claim under the ABIT.

· Ongoing discussions with a potential new joint venture partner.

We have seen 900m shares traded since Monecor last TR1

So are we saying they have just sold 5 million shares lol

Looks like they sold everything and bought back for clients again after noticing the upside

https://www.proactiveinvestors.com/companies/amp/news/966530